ARCHIVES

DCT To Renegotiate Cooperative Groups Term Of Award, Considering Other Major Changes

This article is from The Cancer Letter archive.

Vol. 14 No. 10 | March 4, 1988

Download PDF Visit The Full Archive

Related Articles

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

June 3, 2011

NCAB Votes Down Effort to Delay CCOP RFA, Directs Subcommittee To Look Again A Program Components

February 12, 1982

Congress Plans to Accelerate Development of Drugs, Devices

December 19, 2014

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

No Protective Effect From Long-Term Vitamin E or C

November 28, 2008

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001